- Home
- CDLR vs PLSE Comparison
CDLR vs PLSE Comparison
Compare CDLR & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CDLR | PLSE |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | Denmark | United States |
| Employees | 1104 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2023 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CDLR | PLSE |
|---|---|---|
| Price | $21.91 | $27.73 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | 77.9K | ★ 360.1K |
| Earning Date | 05-20-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $53.56 | $840.00 |
| Revenue Next Year | $32.79 | $287.54 |
| P/E Ratio | $7.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.37 | $12.56 |
| 52 Week High | $30.01 | $31.00 |
Technical Indicators
Market Signals| Indicator | CDLR | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 37.42 | 60.25 |
| Support Level | $21.71 | $23.94 |
| Resistance Level | $22.02 | N/A |
| Average True Range (ATR) | 0.50 | 2.02 |
| MACD | 0.03 | 0.24 |
| Stochastic Oscillator | 54.25 | 58.84 |
Price Performance
Historical ComparisonAbout CDLR Cadeler AS
Cadeler AS is an offshore wind installation vessel contractor. It currently operates various offshore jack-up wind installation vessels, with new builds on order. The Group operates within the market for the transportation and installation of offshore wind turbine generators (WTGs) and their foundations. In addition to wind farm installation, its vessels can perform maintenance, decommissioning, and other general construction tasks within the offshore industry. Cadler's customer base consists of offshore wind farm developers, original equipment manufacturers, and various offshore contractors. Geographically, the Group generates maximum revenue from the United States and the rest from the United Kingdom, Taiwan, Germany, Denmark, Poland, and other regions.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.